The company now operates in 104 countries with 51 webshops, more than 4,800 B2B partners, 332 European stores, and a portfolio of over 2,000 products.
Export markets drove growth in 2025, including a more than 20% expansion in the Balkans, strong gains in the Baltics, and a twofold increase in Latin America. New markets opened in Turkey, Saudi Arabia, and Sri Lanka.
Looking ahead to 2026, the company targets more than 10% growth as new production capacities, automated logistics, and AI‑supported operations come fully online.
In th e long term, BioTechUSA aims to reach EUR 1 bln in revenue, supported by a leadership shift. From Jan. 1, Diána Markovics took on the CEO position, while the owners, Bálint and Balázs Lévai, have moved to supervisory board roles.



